DK2986731T3 - Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner - Google Patents

Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner Download PDF

Info

Publication number
DK2986731T3
DK2986731T3 DK14724974.2T DK14724974T DK2986731T3 DK 2986731 T3 DK2986731 T3 DK 2986731T3 DK 14724974 T DK14724974 T DK 14724974T DK 2986731 T3 DK2986731 T3 DK 2986731T3
Authority
DK
Denmark
Prior art keywords
expression
biologically active
elevated levels
synthesis system
active proteins
Prior art date
Application number
DK14724974.2T
Other languages
English (en)
Inventor
Alice Yam
Christopher D Thanos
Dan Groff
Patrick Rivers
Original Assignee
Sutro Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutro Biopharma Inc filed Critical Sutro Biopharma Inc
Application granted granted Critical
Publication of DK2986731T3 publication Critical patent/DK2986731T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK14724974.2T 2013-04-19 2014-04-18 Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner DK2986731T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361813914P 2013-04-19 2013-04-19
US201461937069P 2014-02-07 2014-02-07
PCT/US2014/034643 WO2014172631A2 (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression

Publications (1)

Publication Number Publication Date
DK2986731T3 true DK2986731T3 (da) 2022-08-01

Family

ID=50733442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14724974.2T DK2986731T3 (da) 2013-04-19 2014-04-18 Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner

Country Status (14)

Country Link
US (3) US10190145B2 (da)
EP (1) EP2986731B1 (da)
JP (2) JP6463732B2 (da)
KR (1) KR102289258B1 (da)
CN (1) CN105283556B (da)
AU (1) AU2014253785B2 (da)
CA (1) CA2909516C (da)
DK (1) DK2986731T3 (da)
ES (1) ES2922358T3 (da)
HK (1) HK1220993A1 (da)
HU (1) HUE059565T2 (da)
IL (1) IL242148B (da)
SG (2) SG10202108497TA (da)
WO (1) WO2014172631A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2986731T3 (da) * 2013-04-19 2022-08-01 Sutro Biopharma Inc Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner
WO2016004024A1 (en) * 2014-07-02 2016-01-07 Sutro Biopharma, Inc. High growth capacity auxotrophic escherichia coli and methods of use
WO2016073791A1 (en) 2014-11-05 2016-05-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
KR102544705B1 (ko) 2014-11-05 2023-06-15 제넨테크, 인크. 박테리아 내 2쇄 단백질을 생산하는 방법
EP3234170A4 (en) * 2014-12-19 2018-07-25 Sutro Biopharma, Inc. Codon optimization for titer and fidelity improvement
KR102489471B1 (ko) * 2014-12-30 2023-01-18 셀진 코포레이션 항-cd47 항체 및 그 용도
AU2016230018A1 (en) * 2015-03-06 2017-09-21 Genentech, Inc. Ultrapurified DsbA and DsbC and methods of making and using the same
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
BR112018003127A2 (pt) * 2015-08-20 2018-09-25 Genentech Inc purificação de fkpa e usos do mesmo para produzir polipeptídeos recombinantes
CN105198983B (zh) * 2015-09-11 2018-11-06 中国石油大学(华东) 一种利于七次跨膜蛋白ccr5功能性表达的方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CN106399352B (zh) * 2016-11-09 2020-04-17 华东理工大学 调节目标蛋白表达的折叠因子及其应用
JP7186166B2 (ja) 2016-12-30 2022-12-08 バックスサイト・インコーポレイテッド 非天然アミノ酸とのポリペプチド抗原接合体
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
WO2018126287A1 (en) * 2016-12-30 2018-07-05 Ntxbio, Llc Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
AR112756A1 (es) 2017-07-11 2019-12-11 Synthorx Inc Incorporación de nucleótidos no naturales, y su método
KR20200035092A (ko) 2017-08-03 2020-04-01 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
JP2020533018A (ja) * 2017-08-11 2020-11-19 シンビトロバイオ, インコーポレイテッド 改善されたインビトロ転写/翻訳(txtl)システムおよびその使用
WO2019127469A1 (zh) * 2017-12-29 2019-07-04 康码(上海)生物科技有限公司 一种高效的能源再生体系(bes)、试剂盒及其制备方法
JP7340591B2 (ja) 2018-07-11 2023-09-07 アクティム・セラピューティクス・インコーポレイテッド 遺伝子操作された免疫刺激性細菌菌株およびその使用
JP2022506156A (ja) * 2018-11-05 2022-01-17 ジェネンテック, インコーポレイテッド 原核宿主細胞における2鎖タンパク質の産生方法
JP7426389B2 (ja) * 2018-11-08 2024-02-01 ストロ バイオファーマ, インコーポレイテッド 酸化的細胞質を有する大腸菌株
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
TW202045208A (zh) 2019-02-06 2020-12-16 美商欣爍克斯公司 Il-2結合物及其使用方法
TW202120128A (zh) 2019-08-15 2021-06-01 美商欣爍克斯公司 使用il-2接合物之免疫腫瘤學組合療法
BR112022003335A2 (pt) 2019-09-10 2022-05-24 Synthorx Inc Conjugados de il-2 e métodos de uso para tratar doenças autoimunes
TW202131952A (zh) 2019-11-04 2021-09-01 美商欣爍克斯公司 介白素10接合物及其用途
EP4114931A4 (en) * 2020-03-05 2024-05-01 Curie Co. Inc. METHODS FOR CELL PROTEIN EXPRESSION OF MATURE POLYPEPTIDES DERIVED FROM ZYMOGENS AND PROPROTEINS
CA3175683A1 (en) * 2020-04-29 2021-11-04 Xueyang FENG Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
CA3183834A1 (en) 2020-06-25 2021-12-30 Giovanni Abbadessa Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies
KR20220000028U (ko) 2020-06-29 2022-01-05 채인자 농작물용 농약 간편 분무장치
US20220089690A1 (en) * 2020-09-14 2022-03-24 Sutro Biopharma, Inc. Method for large scale production of antibodies using a cell-free protein synthesis system
EP4225376A1 (en) 2020-10-09 2023-08-16 Synthorx, Inc. Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
CA3194880A1 (en) 2020-10-09 2022-04-14 Carolina E. CAFFARO Immuno oncology therapies with il-2 conjugates
WO2022174102A1 (en) 2021-02-12 2022-08-18 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
TW202245843A (zh) 2021-02-12 2022-12-01 美商欣爍克斯公司 Il-2接合物及西米普利單抗(cemiplimab)之皮膚癌組合療法
WO2022256534A1 (en) 2021-06-03 2022-12-08 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122573A1 (en) 2021-12-20 2023-06-29 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
CN115028691A (zh) * 2022-06-29 2022-09-09 青岛硕景生物科技有限公司 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用
CN118048325A (zh) * 2024-04-16 2024-05-17 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145694A1 (de) 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
US20060134739A1 (en) * 2003-03-11 2006-06-22 Chatterjee Deb K Synthesis of proteins by cell-free protein expression
JP2005253432A (ja) * 2004-03-15 2005-09-22 Sekisui Chem Co Ltd タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット
JP4561243B2 (ja) * 2004-08-27 2010-10-13 株式会社豊田中央研究所 無細胞タンパク質合成系のための媒体
CN101479379B (zh) * 2006-06-29 2012-01-18 利兰·斯坦福青年大学托管委员会 含有非天然氨基酸的蛋白质的无细胞合成
CA2673765A1 (en) * 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
WO2010081110A1 (en) 2009-01-12 2010-07-15 Sutro Biopharma, Inc. Dual charging system for selectively introducing non-native amino acids into proteins using an in vitro synthesis method
CN102732548A (zh) 2012-05-16 2012-10-17 中国农业大学 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用
DK2986731T3 (da) 2013-04-19 2022-08-01 Sutro Biopharma Inc Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner

Also Published As

Publication number Publication date
EP2986731A2 (en) 2016-02-24
AU2014253785B2 (en) 2018-07-19
US20140315245A1 (en) 2014-10-23
KR20160002913A (ko) 2016-01-08
KR102289258B1 (ko) 2021-08-11
JP2018157837A (ja) 2018-10-11
US20210054429A1 (en) 2021-02-25
AU2014253785A1 (en) 2015-11-05
US20190161781A1 (en) 2019-05-30
CA2909516A1 (en) 2014-10-23
SG11201508642WA (en) 2015-11-27
ES2922358T3 (es) 2022-09-13
CN105283556B (zh) 2020-07-14
CA2909516C (en) 2023-03-07
HUE059565T2 (hu) 2022-11-28
JP6463732B2 (ja) 2019-02-06
EP2986731B1 (en) 2022-05-18
JP2016518833A (ja) 2016-06-30
CN105283556A (zh) 2016-01-27
WO2014172631A2 (en) 2014-10-23
US10774354B2 (en) 2020-09-15
IL242148B (en) 2019-03-31
WO2014172631A3 (en) 2014-12-18
WO2014172631A4 (en) 2015-02-19
SG10202108497TA (en) 2021-09-29
US10190145B2 (en) 2019-01-29
HK1220993A1 (zh) 2017-05-19

Similar Documents

Publication Publication Date Title
DK2986731T3 (da) Ekspression af biologisk aktive proteiner i et bakteriecellefrit syntesesystem ved hjælp af celleekstrakter med forhøjede niveauer af exogene chaperoner
CL2016001190A1 (es) Cultivo de células de mamífero.
BR112015030946A2 (pt) composição compreendendo uma célula ß pancreática não-nativa, método de diferenciação de células progenitoras em células ß pancreáticas in vitro e uso de uma célula ß pancreática não-nativa
DK3351620T3 (da) Metabolsk optimeret cellekultur
DK2780022T3 (da) Farmaceutiske præparater af humane rpe-celler og anvendelser deraf
SMT201500055B (it) Dispositivi e metodi per la coltura di cellule
GB2561496A (en) Devices and methods for simulating a function of a liver tissue
DK2705143T3 (da) Protein-induceret pluripotent celleteknologi og anvendelse deraf
EP2811011A4 (en) CELL CULTURE KIT AND METHOD FOR USING THE CELL CULTURE KIT
DK2998289T3 (da) Forbindelser til at målrette lægemiddellevering og fremme sirna-aktivitet
SG2014013676A (en) Therapeutics using adipose cells and cell secretions
DK2718416T3 (da) Ekspansion af stamceller i hulfiberbioreaktorer
EP2968549A4 (en) CELL CULTURE METHODS
UY34017A (es) Proteínas de fusión y vacunas de combinación
EP2971040A4 (en) CELL CULTURE METHODS
EP2971014A4 (en) CELL CULTURE METHODS
DK2744456T3 (da) Forbedringer ved eller i forbindelse med proteser og ortoser
CO6870031A2 (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
CO6870003A2 (es) Vacunas bovinas y métodos
UY34124A (es) Cerramiento y método para conformarlo
BR112014002624A2 (pt) microorganismo recombinante e cultura de microorganismo recombinante
DK2753346T3 (da) Ceramidase og celledifferentiering
BR112013033166A2 (pt) método microbiológico de produção de uma solução de dextrano, solução de dextrano nativo e seu uso
DK2938186T3 (da) Organ- og vævsbevaringsformuleringer med øget stabilitet og holdbarhed
SG10201806083RA (en) Microcarrier perfusion culturing methods and uses thereof